AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 46 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $176,000 | +4.1% | 12,500 | -12.9% | 0.00% | 0.0% |
| Q4 2017 | $169,000 | +19.0% | 14,350 | +42.8% | 0.00% | +33.3% |
| Q3 2017 | $142,000 | +7.6% | 10,050 | +6.9% | 0.00% | 0.0% |
| Q2 2017 | $132,000 | -21.0% | 9,400 | -6.5% | 0.00% | -25.0% |
| Q1 2017 | $167,000 | +6.4% | 10,050 | +5.2% | 0.00% | 0.0% |
| Q4 2016 | $157,000 | +685.0% | 9,550 | +536.7% | 0.00% | – |
| Q3 2016 | $20,000 | +122.2% | 1,500 | 0.0% | 0.00% | – |
| Q2 2016 | $9,000 | +12.5% | 1,500 | +50.0% | 0.00% | – |
| Q1 2016 | $8,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 877,753 | $11,727,000 | 5.26% |
| RA Capital Management | 2,191,977 | $29,285,000 | 3.02% |
| NEXTHERA CAPITAL LP | 340,000 | $4,542,000 | 2.79% |
| Opaleye Management Inc. | 310,000 | $4,142,000 | 2.17% |
| Baker Brothers Advisors | 10,536,092 | $140,762,000 | 1.28% |
| Ghost Tree Capital, LLC | 250,000 | $3,340,000 | 0.54% |
| Cormorant Asset Management, LP | 151,838 | $2,029,000 | 0.22% |
| DAFNA Capital Management LLC | 20,000 | $267,000 | 0.19% |
| ELLINGTON MANAGEMENT GROUP LLC | 10,800 | $144,000 | 0.04% |
| Alyeska Investment Group, L.P. | 272,163 | $3,636,000 | 0.03% |